Literature DB >> 15754975

Apolipoprotein E polymorphism is related to plasma lipids and apolipoproteins in Mexican adolescents.

Aida X Medina-Urrutia1, Guillermo C Cardoso-Saldaña, José Zamora-González, Yamamoto K Liria, Carlos Posadas-Romero.   

Abstract

Previous studies in the Mexican population have failed to show an effect of apolipoprotein E (APOE) polymorphism on the lipid profile. The purpose of the present study was to determine the frequencies of APOE phenotypes, and their influence on lipid and apolipoprotein levels in a random sample of Mexican adolescents living in Mexico City. APOE polymorphism, fasting insulin levels, lipid levels, and apolipoprotein levels were determined in 420 adolescents. We found a high frequency of APOE*3 subjects (89.5%) and a low frequency of APOE*2 (3.0%) and APOE*4 (7.5%) subjects. The APOE*4 subjects (including APOE 4,3 and APOE 4,4) showed the highest concentrations of total cholesterol, low-density lipoprotein cholesterol, and apoB and the lowest high-density lipoprotein cholesterol levels, whereas carriers of the APOE*2 allele (APOE 3,2 and APOE 2,2) had the lowest values for total and low-density lipoprotein cholesterol and the highest concentrations of high-density lipoprotein cholesterol. No significant differences in triglyceride and insulin levels among subjects with different APOE polymorphisms were observed. Unlike previous studies in the Mexican population, our results show that lipid and lipoprotein levels are under the influence of APOE polymorphism. As in whites, APOE*4 may be a cardiovascular risk factor in the Mexican population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15754975     DOI: 10.1353/hub.2004.0059

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  11 in total

1.  Distribution and effect of apo E genotype on plasma lipid and apolipoprotein profiles in overweight/obese and nonobese Chinese subjects.

Authors:  Juan Zhang; Ping Fan; Rui Liu; Yi Huang; Shanshan Liang; Yu Liu; Yin Wu; Huai Bai
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

2.  Association of cholesteryl ester transfer protein (TaqIB) and apolipoprotein E (HhaI) gene variants with obesity.

Authors:  Neena Srivastava; B R Achyut; Jai Prakash; C G Agarwal; D C Pant; Balraj Mittal
Journal:  Mol Cell Biochem       Date:  2008-05-04       Impact factor: 3.396

3.  APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population.

Authors:  Rafael O Alvim; Silvia R S Freitas; Noely E Ferreira; Paulo C J L Santos; Roberto S Cunha; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  Lipids Health Dis       Date:  2010-11-08       Impact factor: 3.876

4.  A Common APOE Polymorphism Is an Independent Risk Factor for Reduced Glomerular Filtration Rate in the Spanish RENASTUR Cohort.

Authors:  Eliecer Coto; Juan Gómez; Beatriz Tavira; Salvador Tranche; Francisco Ortega; María I Rodríguez; Emilio Sánchez; Rafael Marín; Ana I Corao; Jorge Arenas; Victoria Alvarez
Journal:  Cardiorenal Med       Date:  2013-05-16       Impact factor: 2.041

5.  Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention.

Authors:  José M Ordovas
Journal:  Am J Clin Nutr       Date:  2009-04-01       Impact factor: 7.045

6.  APOE genotype and cardio-respiratory fitness interact to determine adiposity in 8-year-old children from the Tasmanian Infant Health Survey.

Authors:  Justine A Ellis; Anne-Louise Ponsonby; Angela Pezic; Elizabeth Williamson; Jennifer A Cochrane; Joanne L Dickinson; Terence Dwyer
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

7.  Comprehensive evaluation of the association of APOE genetic variation with plasma lipoprotein traits in U.S. whites and African blacks.

Authors:  Zaheda H Radwan; Xingbin Wang; Fahad Waqar; Dilek Pirim; Vipavee Niemsiri; John E Hokanson; Richard F Hamman; Clareann H Bunker; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

8.  Apolipoprotein E genotypes among diverse middle-aged and older Latinos: Study of Latinos-Investigation of Neurocognitive Aging results (HCHS/SOL).

Authors:  Hector M González; Wassim Tarraf; Xueqiu Jian; Priscilla M Vásquez; Robert Kaplan; Bharat Thyagarajan; Martha Daviglus; Melissa Lamar; Linda C Gallo; Donglin Zeng; Myriam Fornage
Journal:  Sci Rep       Date:  2018-12-13       Impact factor: 4.379

9.  Impact of APOE gene polymorphisms on the lipid profile in an Algerian population.

Authors:  Houssam Boulenouar; Sounnia Mediene Benchekor; Djabaria Naïma Meroufel; Sarah Aicha Lardjam Hetraf; Hadjira Ouhaibi Djellouli; Xavier Hermant; Benjamin Grenier-Boley; Imane Hamani Medjaoui; Nadhira Saidi Mehtar; Philippe Amouyel; Leila Houti; Aline Meirhaeghe; Louisa Goumidi
Journal:  Lipids Health Dis       Date:  2013-10-25       Impact factor: 3.876

10.  Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.

Authors:  Mauro Sergio Martins Marrocos; Andrei Alkmin Teixeira; Beata Marie Quinto; Silmara de Melo Carmona; Mariana Kuniyoshi; Cassio Jose Rodrigues; Maria Aparecida Dalboni; Silvia Manfredi; Maria Eugênia Canziani; Marcelo Costa Batista
Journal:  Lipids Health Dis       Date:  2016-01-20       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.